Ftibamzone

酞丁安

Report date: 2023/08/14 11:17:33
NME

Base Information

Drug NameFtibamzone
Drug Alias Name酚丁安增光素V6133TDA华太
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsProtein synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsHerpes ZosterHerpes SimplexCondylomata Acuminata +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesInstitue Of Materia Medica Chinese Academy Of Medical Science
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHerpes ZosterHerpes SimplexCondylomata Acuminata +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A